3M fell on hard times but could be set to rebound soon.
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
It's likely the deal goes through, but I don't believe that attempting to take advantage of FIT's current 11% discount is worth the risk.
Our latest analysis on the fitness chain.
As it smooths out the wrinkles from 2019, this pharmaceutical manufacturer should have a healthy year.
I expect PLNT to outperform over the next six weeks.
Let's check out two charts.
It looks like JNJ has its swagger back.
Two food-related names and one in health care look like promising investments right now.